Search - tctmd.com

Displaying 961 - 980 of 1042

Sort: Relevancy | Date

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Conference News ESC 2012

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

August 26, 2012

News Daily News

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

L.A. McKeown

August 20, 2012

News Daily News

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

L.A. McKeown

August 20, 2012

Presentation

Initial and Chronic Response to Clopidogrel After Stenting for ACS and Influence on Clinical Outcomes

Presenter: Thomas Cuisset

August 17, 2012

News Daily News

Las Infecciones tras una PCI Primaria son Raras pero Serias

August 07, 2012

Presentation

Prior Smoking Status, Clinical Outcomes, and the Comparison of Ticagrelor with Clopidogrel in ACS

Presenter: Jan H. Cornel

August 02, 2012

News Daily News

Stopping Clopidogrel 1 Year After MI Raises Risk in PCI Patients

Jason Kahn

July 20, 2012

News Daily News

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

July 10, 2012

News Daily News

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

July 05, 2012

News Daily News

Meta-analysis: Early Invasive Strategy Best for Diabetic Patients with NSTE ACS

July 03, 2012

News Daily News

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

June 26, 2012

News Daily News

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Caitlin E. Cox

June 07, 2012

News Daily News

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Caitlin E. Cox

June 07, 2012

News Daily News

Un Meta Análisis Favorece el Abciximab Intracoronario frente al Abciximab Intravenoso en PCI Primarias

June 05, 2012

News Daily News

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

June 05, 2012

News Daily News

Post-Conditioning Decreases Infarct Size, Edema after Reperfusion Therapy for STEMI

Leah Lawrence

June 05, 2012

Presentation

Clinical Impact of Intracoronary Abciximab in Patients Undergoing Primary PCI

Presenter: R. Piccolo

June 04, 2012

News Daily News

PLATO Substudy: ACS Patients with Prior Stroke at No Disadvantage with Ticagrelor

Yael L. Maxwell

June 01, 2012

News Daily News

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

May 09, 2012

Advertisement

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

Initial and Chronic Response to Clopidogrel After Stenting for ACS and Influence on Clinical Outcomes

Las Infecciones tras una PCI Primaria son Raras pero Serias

Prior Smoking Status, Clinical Outcomes, and the Comparison of Ticagrelor with Clopidogrel in ACS

Stopping Clopidogrel 1 Year After MI Raises Risk in PCI Patients

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

Meta-analysis: Early Invasive Strategy Best for Diabetic Patients with NSTE ACS

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Un Meta Análisis Favorece el Abciximab Intracoronario frente al Abciximab Intravenoso en PCI Primarias

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

Post-Conditioning Decreases Infarct Size, Edema after Reperfusion Therapy for STEMI

Clinical Impact of Intracoronary Abciximab in Patients Undergoing Primary PCI

PLATO Substudy: ACS Patients with Prior Stroke at No Disadvantage with Ticagrelor

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content